Roe, Matthew T.
University of North Carolina at Chapel Hill · University of Iowa · Pennsylvania State University · University of Pittsburgh · Duke University · Vanderbilt University · University of Florida · Duke Clinical Research Institute · Wake Forest University · Temple University
12 papers on CoChatORCID 0000-0002-4049-3458
Most cited papers
- Verified
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
Schwartz, G. G., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., Harrington, R. A., et al. (2018) · New England Journal of Medicine
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 3,634
- Verified
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial
Hernandez, A. F., Green, J. B., Janmohamed, S., D'Agostino, R. B., Granger, C. B., Jones, N. P., Leiter, L. A., Rosenberg, A. E., Sigmon, K. N., Somerville, M. C., et al. (2018) · The Lancet
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 1,829
- Verified
Prasugrel versus clopidogrel for acute coronary syndromes without revascularization
Roe, M. T., Armstrong, P. W., Fox, K. A. A., White, H. D., Prabhakaran, D., Goodman, S. G., Cornel, J. H., Bhatt, D. L., Clemmensen, P., Martinez, F., et al. (2012) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 874
- Verified
Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome
Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., Fras, Z., Goodman, S. G., Halvorsen, S., Hanotin, C., et al. (2020) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 572
- Verified · note
Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry
Fox, C. S., Muntner, P., Chen, A. Y., Alexander, K. P., Roe, M. T., Cannon, C. P., Saucedo, J. F., Kontos, M. C., & Wiviott, S. D. (2010) · Circulation
Acute Myocardial Infarction ResearchCoronary Interventions and Diagnostics
Cited by 458
- Verified
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial
Schwartz, G. G., Bessac, L., Berdan, L. G., Bhatt, D. L., Bittner, V., Diaz, R., Goodman, S. G., Hanotin, C., Harrington, R. A., Jukema, J. W., et al. (2014) · American Heart Journal
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 408
- Verified
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease
Jones, W. S., Mulder, H., Wruck, L. M., Pencina, M. J., Kripalani, S., Muñoz, D., Crenshaw, D. L., Effron, M. B., Re, R. N., Gupta, K., et al. (2021) · New England Journal of Medicine
Antiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction Research
Cited by 307
- Verified
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome
Jukema, J. W., Szarek, M., Zijlstra, L. E., de Silva, H. A., Bhatt, D. L., Bittner, V. A., Diaz, R., Edelberg, J. M., Goodman, S. G., Hanotin, C., et al. (2019) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 243
- Verified
Cardiovascular Drug Development
Fordyce, C. B., Roe, M. T., Ahmad, T., Libby, P., Borer, J. S., Hiatt, W. R., Bristow, M. R., Packer, M., Wasserman, S. M., Braunstein, N., et al. (2015) · Journal of the American College of Cardiology
Pharmaceutical Economics and PolicyPharmaceutical industry and healthcare
Cited by 202
- Verified · note
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events
Szarek, M., White, H. D., Schwartz, G. G., Alings, M., Bhatt, D. L., Bittner, V. A., Chiang, C.-E., Diaz, R., Edelberg, J. M., Goodman, S. G., et al. (2019) · Journal of the American College of Cardiology
Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research
Cited by 173
- Verified
Applying novel methods to assess clinical outcomes: insights from the TRILOGY ACS trial
Bakal, J. A., Roe, M. T., Ohman, E. M., Goodman, S. G., Fox, K. A. A., Zheng, Y., Westerhout, C. M., Hochman, J. S., Lokhnygina, Y., Brown, E. B., et al. (2015) · European Heart Journal
Statistical Methods in Clinical TrialsAntiplatelet Therapy and Cardiovascular Diseases
Cited by 59
- Verified
Percutaneous coronary intervention for older adults who present with syncope and coronary artery disease? Insights from the National Cardiovascular Data Registry
Anderson, L. L., Dai, D., Miller, A. L., Roe, M. T., Messenger, J. C., & Wang, T. Y. (2016) · American Heart Journal
Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics
Cited by 18
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free